FDA Brain Simulator Will Allow Evaluation Of Electrostimulation Devices On Human Nerve Cells
This article was originally published in The Gray Sheet
Executive Summary
FDA's device center is developing computational models of the human brain to help regulators and device designers assess the physiological effects of electromagnetic fields – such as those generated by implanted nerve stimulators – on the nervous system.
You may also be interested in...
Medical Device Innovation Consortium Sets Priorities To Advance Regulatory Science
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month: Heads of the newly formed private-public partnership comprising industry, academia, and FDA describe the group’s top three projects to advance medical device regulatory science.
Medical Device Innovation Consortium Sets Priorities To Advance Reg Science
The heads of the newly formed private-public partnership comprising industry, academia and FDA describe the group’s top three projects to advance medical device regulatory science.
CDRH Seeks To Increase Ranks Of Validated Computer Simulations
FDA’s device center says it wants to accelerate the evolution of physiological computer simulations from their current use as tools to tweak medical device designs to a future where they are fundamental components of a more streamlined device performance assessment.